Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease
✍ Scribed by Parnetti, Lucilla; Chiasserini, Davide; Persichetti, Emanuele; Eusebi, Paolo; Varghese, Shiji; Qureshi, Mohammad M.; Dardis, Andrea; Deganuto, Marta; De Carlo, Claudia; Castrioto, Anna; Balducci, Chiara; Paciotti, Silvia; Tambasco, Nicola; Bembi, Bruno; Bonanni, Laura; Onofrj, Marco; Rossi, Aroldo; Beccari, Tommaso; El-Agnaf, Omar; Calabresi, Paolo
- Book ID
- 125473078
- Publisher
- John Wiley and Sons
- Year
- 2014
- Tongue
- English
- Weight
- 379 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Recent studies have shown a genetic association between glucocerebrosidase deficiencies and Parkinson's disease (PD). To further explore this issue the activity of β‐glucocerebrosidase and the activities of other lysosomal enzymes, α‐mannosidase, β‐mannosidase, β‐hexosaminidase, and β‐g
## Abstract Although alpha‐synuclein is the main constituent of Lewy bodies, cerebrospinal fluid determination on its own does not seem fundamental for the diagnosis of synucleinopathies. We evaluated whether the combination of classical biomarkers, Aβ~1–42~, total tau, phosphorylated tau, and α‐sy
## Abstract Whole gene duplications and triplications of __alpha‐synuclein__ (__SNCA__) can cause Parkinson's disease (PD), and variation in the promoter region (Rep1) and 3' region of __SNCA__ has been reported to increase disease susceptibility. Within our cohort, one affected individual from eac